Next Article in Journal
Potentiating Gentamicin Efficacy Against Biofilms of Clinically Relevant Gram-Negative Bacteria Using Biosynthesized ZnO Nanoparticles
Previous Article in Journal
Ion- and pH-Responsive In Situ Gel Incorporating Luteolin-Loaded Nanostructured Lipid Carriers Enhances Ocular Bioavailability and Anti-Angiogenic Efficacy for Corneal Neovascularization
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 18
Issue 8
10.3390/pharmaceutics18080912
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Pharmaceutics 2026, 18(5), 628.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Alarcia-Lacalle et al. Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study. Pharmaceutics 2026, 18, 628

by
Ana Alarcia-Lacalle
1,
Miguel Ángel Morán-Rodríguez
2,3,
Laura Morata
4,
Arantxa Isla
1,3,
Andrés Canut-Blasco
3,5 and
Alicia Rodríguez-Gascón
1,3,*
1
Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Lascaray Research Centre, University of the Basque Country EHU, Paseo de la Universidad n° 7, 01006 Vitoria-Gasteiz, Spain
2
Infectious Disease Division, Araba University Hospital, Osakidetza Basque Health Service, Francisco Leandro de Viana Kalea, 01009 Vitoria-Gasteiz, Spain
3
Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy, Bioaraba Health Research Institute, Jose Atxotegi Kalea s/n, 01009 Vitoria-Gasteiz, Spain
4
Department of Infectious Diseases, Hospital Clínic of Barcelona, University of Barcelona, Carrer de Villarroel, 170, 08036 Barcelona, Spain
5
Microbiology Service, Araba University Hospital, Osakidetza Basque Health Service, Francisco Leandro de Viana Kalea, 01009 Vitoria-Gasteiz, Spain
*
Author to whom correspondence should be addressed.
Pharmaceutics 2026, 18(8), 912; https://doi.org/10.3390/pharmaceutics18080912
Submission received: 10 July 2026 / Accepted: 13 July 2026 / Published: 24 July 2026
(This article belongs to the Section Clinical Pharmaceutics)
Browse Figure
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

In the original published paper [...]

Share and Cite

MDPI and ACS Style

Alarcia-Lacalle, A.; Morán-Rodríguez, M.Á.; Morata, L.; Isla, A.; Canut-Blasco, A.; Rodríguez-Gascón, A. Correction: Alarcia-Lacalle et al. Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study. Pharmaceutics 2026, 18, 628. Pharmaceutics 2026, 18, 912. https://doi.org/10.3390/pharmaceutics18080912

AMA Style

Alarcia-Lacalle A, Morán-Rodríguez MÁ, Morata L, Isla A, Canut-Blasco A, Rodríguez-Gascón A. Correction: Alarcia-Lacalle et al. Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study. Pharmaceutics 2026, 18, 628. Pharmaceutics. 2026; 18(8):912. https://doi.org/10.3390/pharmaceutics18080912

Chicago/Turabian Style

Alarcia-Lacalle, Ana, Miguel Ángel Morán-Rodríguez, Laura Morata, Arantxa Isla, Andrés Canut-Blasco, and Alicia Rodríguez-Gascón. 2026. "Correction: Alarcia-Lacalle et al. Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study. Pharmaceutics 2026, 18, 628" Pharmaceutics 18, no. 8: 912. https://doi.org/10.3390/pharmaceutics18080912

APA Style

Alarcia-Lacalle, A., Morán-Rodríguez, M. Á., Morata, L., Isla, A., Canut-Blasco, A., & Rodríguez-Gascón, A. (2026). Correction: Alarcia-Lacalle et al. Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study. Pharmaceutics 2026, 18, 628. Pharmaceutics, 18(8), 912. https://doi.org/10.3390/pharmaceutics18080912

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop